Evidence for the causal role of endogenous interferon-α/β in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms

MF McCarty, D Bielenberg, C Donawho… - Clinical & experimental …, 2002 - Springer
MF McCarty, D Bielenberg, C Donawho, CD Bucana, IJ Fidler
Clinical & experimental metastasis, 2002Springer
Primary tumor growth and metastasis depend on angiogenesis, which is determined by the
balance between proangiogenic and antiangiogenic molecules. Interferon (IFN)-α and-β
inhibit angiogenesis through downregulation of interleukin-8, matrix metalloproteinase-9,
and basic fibroblast growth factor. To provide evidence for the causal role of IFN-α/β in the
induction of neoplasms, their angiogenesis, and hence, progressive growth, we carried out
experiments using 129S6 IFN-α/β receptor−/− mice back-crossed to BALB/c nude mice …
Abstract
Primary tumor growth and metastasis depend on angiogenesis, which is determined by the balance between proangiogenic and antiangiogenic molecules. Interferon (IFN)-α and -β inhibit angiogenesis through downregulation of interleukin-8, matrix metalloproteinase-9, and basic fibroblast growth factor. To provide evidence for the causal role of IFN-α/β in the induction of neoplasms, their angiogenesis, and hence, progressive growth, we carried out experiments using 129S6 IFN-α/β receptor −/− mice back-crossed to BALB/c nude mice. Subcutaneous angiogenesis was determined following implantation of gelfoam sponges containing 0.4% agarose and several proangiogenic molecules. Tumorigenicity and production of lung metastasis were determined subsequent to subcutaneous and intravenous injections, respectively, of highly metastatic A375SM human melanoma cells. Carcinogenesis was induced by chronic exposure of mice to UVB radiation (5 kJ/m2, 3 times/week). Angiogenesis, tumorigenicity, and production of metastasis, as well as development of autochthonous skin tumors, were all accelerated in IFN-α/β receptor −/− mice as compared to control mice. Collectively, the data show that inability to respond to endogenous IFN-α/β (through a mutation in the IFN-α/β receptor) leads to increased susceptibility to carcinogenesis, enhanced angiogenesis, tumorigenicity, and metastasis.
Springer